Cancer Vaccines: 405 (Current Topics in Microbiology and Immunology, 405) - Softcover

Softcover

ISBN 10: 331979552X ISBN 13: 9783319795522

Publisher: Springer, 2018

Synopsis

This volume focuses on the laboratory and clinical experience with targeting viral onco-antigens, while also reviewing the approaches to targeting self-cancer antigens in cancers of non-viral origin, where self-tolerance has been a challenge. It emphasizes the importance of selecting the right vaccine platform to induce a successful immune response against cancer antigens. In addition, the volume discusses the advances made with genetic vaccines, including recent advances with  DNA vaccines and the rapid transition of mRNA vaccines from the laboratory to bedside. The new avenues opening up for cancer immunotherapy underline the importance of combinational approaches using cancer vaccines with costimulatory antibodies, which may dramatically improve cancer treatment.
This book is intended for all translational researchers and clinicians who aspire to develop novel vaccination approaches for cancer patients with unmet clinical needs.

About this title

About the Author

Dr. Natalia Savelyeva is a lecturer in cancer immunology in Southhampton

 Dr. Christian Ottensmeier is a professor of experimental medicine in Southhampton

From the Back Cover

This volume focuses on the laboratory and clinical experience with targeting viral onco-antigens, while also reviewing the approaches to targeting self-cancer antigens in cancers of non-viral origin, where self-tolerance has been a challenge. It emphasizes the importance of selecting the right vaccine platform to induce a successful immune response against cancer antigens. In addition, the volume discusses the advances made with genetic vaccines, including recent advances with  DNA vaccines and the rapid transition of mRNA vaccines from the laboratory to bedside. The new avenues opening up for cancer immunotherapy underline the importance of combinational approaches using cancer vaccines with costimulatory antibodies, which may dramatically improve cancer treatment.
This book is intended for all translational researchers and clinicians who aspire to develop novel vaccination approaches for cancer patients with unmet clinical needs.

Edition details

• Publisher: Springer
• Publication date: 2018
• Language: English
• ISBN 10: 331979552X
• ISBN 13: 9783319795522
• Binding: Paperback
• Number of pages: 210
• Editor: Savelyeva Natalia, Ottensmeier Christian